The METEX study: Methotrexate versus expectant management in women with ectopic pregnancy: A randomised controlled trial

BACKGROUND: Patients with ectopic pregnancy (EP) and low serum hCG concentrations and women with a pregnancy of unknown location (PUL) and plateauing serum hCG levels are commonly treated with systemic methotrexate (MTX). However, there is no evidence that treatment in these particular subgroups of...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: van Mello, Norah M, Mol, Femke, Adriaanse, Albert H, Boss, Erik A, Dijkman, Antonius B, Doornbos, Johannes PR, Emanuel, Mark Hans, Friederich, Jaap, Leeuw-Harmsen, Loes van der, Lips, Jos P, van Santbrink, Evert JP, Verhoeve, Harold R, Visser, Harry, Ankum, Willem M, Veen, Fulco van der, Mol, Ben W, Hajenius, Petra J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2008
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2453103/
https://ncbi.nlm.nih.gov/pubmed/18565217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6874-8-10
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items